Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 208
interventional 146
Observational 56
Registry 6

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 70
Drug|placebo 39
Device 11
Other 6
Drug|Other 3
Procedure 3
Behavioral 1
Behavioral|Drug 1
Behavioral|Drug|placebo 1
Biological 1
Biological|Other 1
Combination Product 1
Device|Drug|Procedure 1
Device|Other 1
Device|Procedure 1
Diagnostic Test|Drug|Other|placebo 1
Dietary Supplement|Other 1
Drug|Procedure 1
Drug|Procedure|Radiation 1
Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 73
Japan 15
Korea, Republic of 10
NA 7
United Kingdom 6
Switzerland 4
Germany 3
China 2
China|Korea, Republic of|Malaysia|Taiwan 2
Russian Federation 2
Taiwan 2
United States|Canada 2
United States|Canada|Denmark|Finland|France|Germany|Italy|Norway|Sweden|United Kingdom 2
China|Korea, Republic of 1
Denmark|Finland|Norway|Sweden 1
Germany|Hungary|United States|Australia|Bulgaria|Canada|Czech Republic|India|Latvia|Lithuania|New Zealand|Peru|Poland|Slovakia|South Africa 1
Greece 1
Italy 1
Spain 1
United States|Australia|Belgium|Canada|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
United States|Australia|Bulgaria|Canada|Colombia|Czech Republic|Germany|India|Latvia|Lithuania|New Zealand|Peru|Poland|Russian Federation|Slovakia|South Africa 1
United States|Australia|Canada|Czech Republic|Estonia|Latvia|Lithuania|Slovakia 1
United States|Australia|Canada|United Kingdom 1
United States|Australia|Netherlands 1
United States|Belgium|Brazil|Hungary|Italy|Mexico|Poland|Portugal 1
United States|Belgium|Canada|Germany|Spain|Switzerland 1
United States|Belgium|France|Italy 1
United States|Bulgaria|Czechia 1
United States|Canada|Switzerland 1

Sites per Study

Site_count Study_Count
1 89
2 4
3 1
4 3
5 2
6 1
7 1
8 1
9 2
11 1
13 1
14 1
15 1
17 1
19 1
20 1
23 1
24 1
29 1
30 1
32 2
36 3
37 2
39 1
41 1
44 1
45 1
54 1
56 1
59 1
61 2
62 1
63 1
64 1
72 1
75 1
77 1
81 1
94 1
96 1
98 1
100 1
140 1
144 1
202 2

Phase

Phase Study_Count
Phase 3 38
N/A 32
Phase 2 32
Phase 4 21
Phase 1 13
Phase 2/Phase 3 6
Early Phase 1 2
Phase 1/Phase 2 2

Number of Arms

Number_of_Arms Count_of_Studies
1 35
2 54
3 23
4 12
5 5
NA 17

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 3.0 5.00000 8.00000 24 10.0000 51.0000 19.0000 3.0000
1st Qu. 6.5 20.50000 19.00000 24 31.0000 82.5000 192.5000 64.0000
Median 10.0 30.00000 22.00000 24 72.0000 178.0000 303.5000 100.0000
Mean 10.0 68.67742 28.38462 24 194.2258 185.1667 432.1579 180.9048
3rd Qu. 13.5 78.00000 41.00000 24 118.0000 281.7500 473.5000 143.0000
Max. 17.0 500.00000 49.00000 24 1400.0000 337.0000 2054.0000 1000.0000

Trial Group Type

group_type Group_Count
Experimental 174
Active Comparator 63
Placebo Comparator 35
NA 17
Other 11
No Intervention 1
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 91
Single Group Assignment 41
Crossover Assignment 10
NA 2
Factorial Assignment 1
Sequential Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 108
Basic Science 10
Diagnostic 7
Supportive Care 6
Other 5
Prevention 5
NA 3
Device Feasibility 1
Screening 1

Observational Studies

Studies by Country

Country Study_Count
United States 37
Japan 6
NA 3
Korea, Republic of 2
Switzerland 2
Austria|Italy|Norway|Spain|Sweden 1
Brazil 1
Finland|Romania 1
Israel|Italy 1
Thailand 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 42
2 1
3 1
5 1
6 3
7 1
8 1
18 1
46 1
47 2
66 1
447 1

Enrollment Metrics

Measure Observational
Min 10.000
1st Qu 55.500
Median 162.000
Mean 2001.339
3rd Qu 862.500
Max 61864.000

Observation Model

observational_model Study_Count
Cohort 27
Case-Only 10
Case-Control 8
Other 6
NA 3
Case Control 2

Time Perspective

time_perspective Study_Count
Prospective 46
Retrospective 5
Other 3
Cross-Sectional 2

Registries

Studies by Country

Country Study_Count
United States 4
NA 1
Spain 1

Sites per Study

Site_count Study_Count
1 4
2 2

Enrollment Metrics

Measure Registries
Min 70.0000
1st Qu 91.0000
Median 100.0000
Mean 309.6667
3rd Qu 400.0000
Max 1000.0000

Registry Model

observational_model Study_Count
Case-Only 3
Cohort 2
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 5
Cross-Sectional 1

Follow-up

target_duration Study_Count
5 Years 2
1 Day 1
1 Year 1
2 Days 1
2 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03078023 Sponge and Eosinophil Peroxidase (EPO) Staining https://ClinicalTrials.gov/show/NCT03078023 Recruiting Mayo Clinic 2021-03-01
NCT04322708 A Study of Antolimab (AK002) in Patients With Active Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT04322708 Recruiting Allakos, Inc. 2021-12-31
NCT03633617 Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT03633617 Recruiting Regeneron Pharmaceuticals 2022-04-22
NCT03553563 A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer https://ClinicalTrials.gov/show/NCT03553563 Recruiting AstraZeneca 2023-01-04
NCT01597674 Effect of 5, 10 or 25 mg of YF476 Daily for 14 Days on Stomach Acidity in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01597674 Completed Trio Medicines Ltd. 1997-06-30
NCT03342391 CEGIR 7808: Use of Unsedated Transnasal Esophagoscopy (TNE) to Monitor Dietary Management of Eosinophilic Esophagitis in Children https://ClinicalTrials.gov/show/NCT03342391 Recruiting Children’s Hospital Medical Center, Cincinnati 2020-07-31
NCT03305653 Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03305653 Recruiting University of Colorado, Denver 2020-12-31
NCT03228147 Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment https://ClinicalTrials.gov/show/NCT03228147 Completed Rutgers, The State University of New Jersey 2017-10-31
NCT03191864 Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT03191864 Active, not recruiting Adare Pharmaceuticals, Inc. 2019-11-08
NCT03116841 Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation https://ClinicalTrials.gov/show/NCT03116841 Completed Takeda 2017-12-20
NCT03029091 An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT03029091 Completed Children’s Hospital Medical Center, Cincinnati 2019-07-22
NCT03006874 Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis https://ClinicalTrials.gov/show/NCT03006874 Completed CJ HealthCare Corporation 2017-03-24
NCT02881372 EoE Food Desensitization https://ClinicalTrials.gov/show/NCT02881372 Recruiting The University of Texas Health Science Center, Houston 2020-05-31
NCT02778867 SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study https://ClinicalTrials.gov/show/NCT02778867 Completed Children’s Hospital Medical Center, Cincinnati 2019-04-17
NCT02755753 A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis https://ClinicalTrials.gov/show/NCT02755753 Completed Severance Hospital 2016-01-31
NCT02736409 An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT02736409 Completed Shire 2019-11-04
NCT02722148 Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET) https://ClinicalTrials.gov/show/NCT02722148 Completed University of North Carolina, Chapel Hill 2018-04-30
NCT02610816 Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids https://ClinicalTrials.gov/show/NCT02610816 Completed Children’s Hospital Medical Center, Cincinnati 2018-05-16
NCT02605837 A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved https://ClinicalTrials.gov/show/NCT02605837 Completed Shire 2019-01-24
NCT02599558 Cytosponge and Dietary Therapy in EoE https://ClinicalTrials.gov/show/NCT02599558 Recruiting Mayo Clinic 2020-12-31
NCT02577393 Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy https://ClinicalTrials.gov/show/NCT02577393 Enrolling by invitation Shandong Cancer Hospital and Institute 2022-06-30
NCT01733147 Modulation of Esophageal Inflammation in Barrett’s Esophagus by Omega-3 Fatty Acids https://ClinicalTrials.gov/show/NCT01733147 Active, not recruiting Mayo Clinic 2021-01-31
NCT03388047 Feasibility of Multi-Spectral Endoscopic Imaging for Detection of Early Neoplasia in Barrett’s Oesophagus https://ClinicalTrials.gov/show/NCT03388047 Recruiting University of Cambridge 2020-12-31
NCT02028663 Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis https://ClinicalTrials.gov/show/NCT02028663 Completed CJ HealthCare Corporation 2014-05-31
NCT02513784 Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome https://ClinicalTrials.gov/show/NCT02513784 Completed Columbia University 2017-12-31
NCT02493335 Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02493335 Active, not recruiting Dr. Falk Pharma GmbH 2018-11-28
NCT02463643 To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis https://ClinicalTrials.gov/show/NCT02463643 Completed Zeria Pharmaceutical 2016-10-31
NCT02456935 Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis https://ClinicalTrials.gov/show/NCT02456935 Completed CJ HealthCare Corporation 2016-07-31
NCT02388724 Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis https://ClinicalTrials.gov/show/NCT02388724 Completed Takeda 2017-07-27
NCT02379052 Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT02379052 Completed Regeneron Pharmaceuticals 2017-02-17
NCT02353078 The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02353078 Completed Mayo Clinic 2016-12-31
NCT02280616 Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02280616 Completed Dr. Falk Pharma GmbH 2013-04-30
NCT02227836 Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02227836 Completed Mayo Clinic 2017-09-30
NCT02204150 Study to Image the Esophagus Using the OFDI Capsule https://ClinicalTrials.gov/show/NCT02204150 Completed Massachusetts General Hospital 2015-07-31
NCT02202590 Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus https://ClinicalTrials.gov/show/NCT02202590 Active, not recruiting Massachusetts General Hospital 2021-12-31
NCT02153398 A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases https://ClinicalTrials.gov/show/NCT02153398 Completed AstraZeneca 2016-04-30
NCT02141711 TAK-438 - Safety, Blood Levels & Effects of Repeated Doses https://ClinicalTrials.gov/show/NCT02141711 Completed Takeda 2009-02-28
NCT02125851 Comparison of Esophageal Clearance Times of Oral Budesonide Preparations https://ClinicalTrials.gov/show/NCT02125851 Completed Walter Reed National Military Medical Center 2014-02-28
NCT02098473 Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02098473 Completed Celgene 2016-02-17
NCT02096458 Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets https://ClinicalTrials.gov/show/NCT02096458 Completed Takeda 2014-02-28
NCT02038894 Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies https://ClinicalTrials.gov/show/NCT02038894 Completed Children’s Hospital Medical Center, Cincinnati 2013-11-30
NCT02019758 Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02019758 Completed University of North Carolina, Chapel Hill 2018-05-31
NCT01999439 EoE(Eosinophilic Esophagitis) https://ClinicalTrials.gov/show/NCT01999439 Completed University of Michigan 2016-04-30
NCT01964131 BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects https://ClinicalTrials.gov/show/NCT01964131 Completed AstraZeneca 2013-12-31
NCT01953575 Mucosal Impedance and Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01953575 Completed Mayo Clinic 2019-06-10
NCT01952847 Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis https://ClinicalTrials.gov/show/NCT01952847 Active, not recruiting M.D. Anderson Cancer Center 2020-12-31
NCT01874535 Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy https://ClinicalTrials.gov/show/NCT01874535 Completed Chang Gung Memorial Hospital 2016-06-30
NCT01860482 The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD https://ClinicalTrials.gov/show/NCT01860482 Completed Chong Kun Dang Pharmaceutical 2015-05-31
NCT01846962 Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01846962 Completed Azienda Policlinico Umberto I 2013-04-30
NCT01733810 The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis https://ClinicalTrials.gov/show/NCT01733810 Completed Dallas VA Medical Center 2015-07-31
NCT01696734 Domperidone in Treating Patients With Gastrointestinal Disorders https://ClinicalTrials.gov/show/NCT01696734 Recruiting M.D. Anderson Cancer Center 2021-10-31
NCT01669811 Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus) https://ClinicalTrials.gov/show/NCT01669811 Completed AstraZeneca 2014-05-31
NCT01642615 Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents https://ClinicalTrials.gov/show/NCT01642615 Completed Takeda 2014-11-30
NCT01642212 OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension https://ClinicalTrials.gov/show/NCT01642212 Completed Shire 2014-10-30
NCT01641913 Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients https://ClinicalTrials.gov/show/NCT01641913 Completed Mayo Clinic 2014-01-31
NCT01630746 A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive Esophagitis https://ClinicalTrials.gov/show/NCT01630746 Completed Takeda 2013-09-30
NCT01599858 Effect of Repeated Doses of YF476, Omeprazole and Placebo on Stomach Acidity in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01599858 Completed Trio Medicines Ltd. 1996-10-31
NCT01585103 Cytosponge Protocol IRB 11-006429 https://ClinicalTrials.gov/show/NCT01585103 Recruiting Mayo Clinic 2021-09-30
NCT01538849 Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis https://ClinicalTrials.gov/show/NCT01538849 Completed Yuhan Corporation 2013-11-30
NCT01538797 Effect of Single Doses of YF476 on Stomach Acidity Compared With Ranitidine and Placebo in Fasted and Fed States https://ClinicalTrials.gov/show/NCT01538797 Completed Trio Medicines Ltd. 1996-08-31
NCT01538784 Safety, Tolerability and Pharmacokinetics of Single Rising Doses of YF476, a Gastrin Antagonist, in Healthy Men https://ClinicalTrials.gov/show/NCT01538784 Completed Trio Medicines Ltd. 1996-06-30
NCT01509261 Efficacy Study of Ilaprazole to Treat Erosive Esophgitis https://ClinicalTrials.gov/show/NCT01509261 Completed Il-Yang Pharm. Co., Ltd. 2011-06-30
NCT01499368 A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients https://ClinicalTrials.gov/show/NCT01499368 Completed Boryung Pharmaceutical Co., Ltd 2012-11-30
NCT01459367 Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive Esophagitis https://ClinicalTrials.gov/show/NCT01459367 Completed Takeda 2013-03-31
NCT01452698 Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis https://ClinicalTrials.gov/show/NCT01452698 Completed Takeda 2012-08-31
NCT01397084 To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole https://ClinicalTrials.gov/show/NCT01397084 Completed AstraZeneca 2012-01-31
NCT01386112 Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01386112 Completed Forest Laboratories 2012-10-31
NCT01381991 The Efficacy of i-Scan for Detecting Reflux Esophagitis https://ClinicalTrials.gov/show/NCT01381991 Completed Konkuk University Hospital 2010-11-30
NCT04281108 Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2) https://ClinicalTrials.gov/show/NCT04281108 Recruiting Adare Pharmaceuticals, Inc. 2021-10-31
NCT04255693 Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence https://ClinicalTrials.gov/show/NCT04255693 Recruiting Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology 2023-12-31
NCT04225026 Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer https://ClinicalTrials.gov/show/NCT04225026 Recruiting Galera Therapeutics, Inc. 2021-12-31
NCT04171986 Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis https://ClinicalTrials.gov/show/NCT04171986 Recruiting Tianjin Medical University Cancer Institute and Hospital 2021-10-31
NCT04149470 Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE) https://ClinicalTrials.gov/show/NCT04149470 Recruiting University of Colorado, Denver 2021-12-31
NCT04124926 Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis https://ClinicalTrials.gov/show/NCT04124926 Recruiting Phathom Pharmaceuticals, Inc. 2021-07-01
NCT04070677 Clinical Study Assessing the Effect of ZIVEREL® in Cancer Patients https://ClinicalTrials.gov/show/NCT04070677 Recruiting Grupo de Investigación Clínica en Oncología Radioterapia 2020-09-30
NCT04069429 Radiation Dose in Humans From Orally Administered Tc99m-Heparin https://ClinicalTrials.gov/show/NCT04069429 Recruiting University of Utah 2020-12-31
NCT03245840 Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT03245840 Active, not recruiting Shire 2021-08-31
NCT04022096 Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Esophagitis https://ClinicalTrials.gov/show/NCT04022096 Recruiting CJ HealthCare Corporation 2020-12-31
NCT03781596 EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone https://ClinicalTrials.gov/show/NCT03781596 Recruiting Walter Reed National Military Medical Center 2020-10-02
NCT03736369 Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) https://ClinicalTrials.gov/show/NCT03736369 Completed Daewoong Pharmaceutical Co. LTD. 2019-08-07
NCT03657771 A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03657771 Recruiting Nemours Children’s Clinic 2020-09-30
NCT03656380 Mepo for EoE Study https://ClinicalTrials.gov/show/NCT03656380 Recruiting University of North Carolina, Chapel Hill 2020-12-31
NCT03446118 MRI to Assess Fibrosis in Eosinophilic Esophagitis Patients https://ClinicalTrials.gov/show/NCT03446118 Recruiting Mayo Clinic 2021-01-15
NCT03415451 Explore the Efficiency of Fiberscope-guided Nasogastric Tube Insertion https://ClinicalTrials.gov/show/NCT03415451 Completed National Taiwan University Hospital 2018-07-30
NCT01262560 Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer https://ClinicalTrials.gov/show/NCT01262560 Completed Radiation Therapy Oncology Group 2014-02-28
NCT01093755 Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett’s Esophagus Following Ablation? https://ClinicalTrials.gov/show/NCT01093755 Completed Mayo Clinic 2014-11-30
NCT01056783 Proof of Concept Study of OC000459 in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01056783 Completed Oxagen Ltd 2011-06-30
NCT01040598 Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model https://ClinicalTrials.gov/show/NCT01040598 Completed O & O Alpan LLC 2011-12-31
NCT01022970 Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01022970 Completed Novartis 2012-02-29
NCT01016223 A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01016223 Completed Penn State University 2012-07-31
NCT01008696 An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis https://ClinicalTrials.gov/show/NCT01008696 Completed Janssen Korea, Ltd., Korea 2008-08-31
NCT00961233 Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT00961233 Completed University of North Carolina, Chapel Hill 2011-08-31
NCT00895817 Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00895817 Completed Walter Reed Army Medical Center 2010-10-31
NCT00880906 Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00880906 Completed Vanderbilt University Medical Center 2013-12-31
NCT00872755 Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) https://ClinicalTrials.gov/show/NCT00872755 Completed G. Hatzikosta General Hospital 2008-04-30
NCT03615677 Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis https://ClinicalTrials.gov/show/NCT03615677 Completed Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. 2019-10-18
NCT02995239 A Study to Compare the Pharmacokinetic Characteristics of CJ-12420 https://ClinicalTrials.gov/show/NCT02995239 Completed CJ HealthCare Corporation 2015-04-30
NCT02679508 Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety https://ClinicalTrials.gov/show/NCT02679508 Active, not recruiting Takeda 2022-02-28
NCT02579876 Milk Patch for Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02579876 Completed Children’s Hospital of Philadelphia 2017-12-20
NCT02434029 Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02434029 Completed Dr. Falk Pharma GmbH 2016-08-04
NCT02388737 Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis https://ClinicalTrials.gov/show/NCT02388737 Completed Takeda 2018-12-24
NCT02371941 Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02371941 Completed University of Tennessee 2017-07-31
NCT01452776 Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis https://ClinicalTrials.gov/show/NCT01452776 Completed Takeda 2013-07-31
NCT04252144 Study of Dietary Patterns and Food Diversity in Russian GERD Patients https://ClinicalTrials.gov/show/NCT04252144 Recruiting Russian Academy of Medical Sciences 2022-09-30
NCT00770913 Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis https://ClinicalTrials.gov/show/NCT00770913 Completed Eisai Inc. 2009-11-30
NCT00762073 Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00762073 Completed Shire 2010-04-30
NCT00728481 The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00728481 Completed Mayo Clinic 2010-12-31
NCT02100189 Esophageal Cytology With FISH in Detecting Esophageal Cancer https://ClinicalTrials.gov/show/NCT02100189 Completed OHSU Knight Cancer Institute 2015-12-31
NCT00693225 Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study https://ClinicalTrials.gov/show/NCT00693225 Completed Mayo Clinic 2010-12-31
NCT00644735 Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed https://ClinicalTrials.gov/show/NCT00644735 Completed AstraZeneca 2004-01-31
NCT00641602 A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis https://ClinicalTrials.gov/show/NCT00641602 Completed AstraZeneca 2003-08-31
NCT00638456 Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00638456 Completed University of California, San Diego 2009-09-30
NCT00635089 Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00635089 Completed Teva Pharmaceutical Industries 2012-01-31
NCT00634114 Reflux Esophagitis Phase III Study (Maintenance Treatment) https://ClinicalTrials.gov/show/NCT00634114 Completed AstraZeneca NA
NCT00633932 Reflux Esophagitis Phase III Study (Initial Treatment) https://ClinicalTrials.gov/show/NCT00633932 Completed AstraZeneca NA
NCT00538434 Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years https://ClinicalTrials.gov/show/NCT00538434 Completed Teva Pharmaceutical Industries 2009-10-31
NCT00523354 Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00523354 Completed Swiss EE Study Group 2007-09-30
NCT00511316 Trial of Montelukast in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00511316 Completed Mayo Clinic 2015-09-30
NCT00471094 Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis https://ClinicalTrials.gov/show/NCT00471094 Completed Takeda 2007-10-31
NCT00426283 A Study of Flovent in Patients With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00426283 Completed Children’s Hospital Medical Center, Cincinnati 2013-01-31
NCT00358449 Intravenous Mepolizumab In Children With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00358449 Completed GlaxoSmithKline 2008-11-25
NCT00321737 Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis https://ClinicalTrials.gov/show/NCT00321737 Completed Takeda 2007-05-31
NCT00284908 Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers https://ClinicalTrials.gov/show/NCT00284908 Completed STEBA France 2006-11-30
NCT00275561 Topical Steroid Treatment for Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00275561 Completed Mayo Clinic 2010-04-30
NCT00274703 An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients https://ClinicalTrials.gov/show/NCT00274703 Completed GlaxoSmithKline 2007-03-31
NCT00271349 Budesonide for Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00271349 Completed Swiss EE Study Group 2008-07-31
NCT00266578 A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders https://ClinicalTrials.gov/show/NCT00266578 Completed Children’s Hospital Medical Center, Cincinnati 2006-11-30
NCT00266565 Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome https://ClinicalTrials.gov/show/NCT00266565 Completed Children’s Hospital Medical Center, Cincinnati 2012-07-31
NCT00256737 Sopran - Omeprazole Treatment Versus Surgery https://ClinicalTrials.gov/show/NCT00256737 Completed AstraZeneca 2005-10-31
NCT00255164 Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis https://ClinicalTrials.gov/show/NCT00255164 Completed Takeda 2006-11-30
NCT00255151 Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis https://ClinicalTrials.gov/show/NCT00255151 Completed Takeda 2006-11-30
NCT00251719 Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis https://ClinicalTrials.gov/show/NCT00251719 Completed Takeda 2007-01-31
NCT00251693 Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis https://ClinicalTrials.gov/show/NCT00251693 Completed Takeda 2007-01-31
NCT00229424 Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine - https://ClinicalTrials.gov/show/NCT00229424 Completed Taiho Pharmaceutical Co., Ltd. 2006-10-31
NCT00228527 Esomeprazole for Treatment of GERD in Pediatric Patients https://ClinicalTrials.gov/show/NCT00228527 Completed AstraZeneca NA
NCT00206284 A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis. https://ClinicalTrials.gov/show/NCT00206284 Completed AstraZeneca NA
NCT00206245 A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis. https://ClinicalTrials.gov/show/NCT00206245 Completed AstraZeneca NA
NCT00206180 NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis https://ClinicalTrials.gov/show/NCT00206180 Completed AstraZeneca NA
NCT00195208 Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis https://ClinicalTrials.gov/show/NCT00195208 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2005-11-30
NCT00175045 Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis https://ClinicalTrials.gov/show/NCT00175045 Completed Takeda 2003-10-31
NCT00133770 Intravenous (IV) Pantoprazole in Erosive Esophagitis https://ClinicalTrials.gov/show/NCT00133770 Completed Emory University 2006-07-31
NCT00123656 Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00123656 Completed University of Utah 2006-12-31
NCT00123630 A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab https://ClinicalTrials.gov/show/NCT00123630 Completed University of Utah 2010-01-31
NCT00081315 Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00081315 Completed MedImmune LLC NA
NCT00005921 A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis https://ClinicalTrials.gov/show/NCT00005921 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002041 Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients https://ClinicalTrials.gov/show/NCT00002041 Completed Bristol-Myers Squibb NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03312686 Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study https://ClinicalTrials.gov/show/NCT03312686 Recruiting Indiana University 2018-12-31
NCT03214952 Drug Use Surveillance of Vonoprazan for “Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis” https://ClinicalTrials.gov/show/NCT03214952 Completed Takeda 2018-10-31
NCT03107819 Metabolomics for Biomarker Discovery in Children With EoE https://ClinicalTrials.gov/show/NCT03107819 Completed The University of Texas Health Science Center, Houston 2018-03-31
NCT02995395 Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT02995395 Recruiting Mayo Clinic 2021-01-05
NCT02897271 Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort https://ClinicalTrials.gov/show/NCT02897271 Active, not recruiting Children’s Hospital Medical Center, Cincinnati 2019-09-30
NCT02775045 Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02775045 Completed University of Wisconsin, Madison 2018-12-13
NCT02546219 a4b7 Integrin in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02546219 Completed Massachusetts General Hospital 2018-12-31
NCT02523118 OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages https://ClinicalTrials.gov/show/NCT02523118 Recruiting Children’s Hospital Medical Center, Cincinnati 2050-12-31
NCT02477475 Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes https://ClinicalTrials.gov/show/NCT02477475 Completed AstraZeneca 2017-02-20
NCT02453126 Fibrostenotic Eosinophilic Esophagitis: Assessment Tools https://ClinicalTrials.gov/show/NCT02453126 Recruiting University of Colorado, Denver 2020-06-30
NCT02320981 Mucosal Impedance in Pediatric Population https://ClinicalTrials.gov/show/NCT02320981 Completed Vanderbilt University Medical Center 2016-09-30
NCT02190513 Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease https://ClinicalTrials.gov/show/NCT02190513 Completed St. John Health System, Michigan 2013-06-30
NCT02072590 Improved Diagnostics of Celiac Disease in Children https://ClinicalTrials.gov/show/NCT02072590 Recruiting Tampere University Hospital 2022-12-31
NCT01306799 To Learn How Bone Structure and Bone Mass Change After Long-term PPI Use https://ClinicalTrials.gov/show/NCT01306799 Completed University of Pennsylvania 2015-04-30
NCT02008903 Esophageal String Test in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02008903 Recruiting University of Colorado, Denver 2020-06-30
NCT01988285 Risk Factors and Biomarkers for Diagnosis and Treatment of EoE https://ClinicalTrials.gov/show/NCT01988285 Enrolling by invitation University of North Carolina, Chapel Hill 2020-08-31
NCT01929824 Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT01929824 Completed Mayo Clinic 2017-09-25
NCT01897506 Assessing Risk of Food Insecurity Within Households of Children With Food Allergy https://ClinicalTrials.gov/show/NCT01897506 Completed Arkansas Children’s Hospital Research Institute 2015-12-31
NCT01865825 Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)? https://ClinicalTrials.gov/show/NCT01865825 Completed Mayo Clinic 2016-12-31
NCT01832324 Molecular Basis of Food Allergy https://ClinicalTrials.gov/show/NCT01832324 Active, not recruiting Children’s Hospital of Philadelphia 2027-12-31
NCT01631591 Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01631591 Completed University of South Florida 2014-07-31
NCT01562639 Nexium Capsules RE Maintenance Specific Clinical Experience Investigation https://ClinicalTrials.gov/show/NCT01562639 Completed AstraZeneca 2014-07-31
NCT01556919 Esophageal Monitoring Device for Assessing Mucosal Impedance https://ClinicalTrials.gov/show/NCT01556919 Enrolling by invitation Vanderbilt University Medical Center 2021-06-30
NCT01536080 Analysis of GERD Symptoms Using Gastroesophageal Reflux Impact Score Questionnaire for Quality of Life https://ClinicalTrials.gov/show/NCT01536080 Completed Seoul National University Bundang Hospital NA
NCT01498497 A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021 https://ClinicalTrials.gov/show/NCT01498497 Completed Forest Laboratories 2013-04-30
NCT01434485 Nexium Capsules Clinical Experience Investigation https://ClinicalTrials.gov/show/NCT01434485 Completed AstraZeneca 2014-03-31
NCT01382563 Registry for Eosinophilic Gastrointestinal Disorders (REGID) https://ClinicalTrials.gov/show/NCT01382563 Active, not recruiting Children’s Hospital Medical Center, Cincinnati 2050-12-31
NCT01323803 Eosinophilic Esophagitis Databank https://ClinicalTrials.gov/show/NCT01323803 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2016-02-29
NCT01322633 Risk of Cancer Among Pantoprazole Users https://ClinicalTrials.gov/show/NCT01322633 Completed Pfizer 2013-03-31
NCT01321567 Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis https://ClinicalTrials.gov/show/NCT01321567 Completed Eisai Inc. 2013-03-01
NCT01921686 Morphological Markers of Gastroesophageal Reflux Disease (GERD) https://ClinicalTrials.gov/show/NCT01921686 Active, not recruiting Baylor College of Medicine 2014-09-30
NCT04416217 Eosinophilic Esophagitis Steroid Safety Study https://ClinicalTrials.gov/show/NCT04416217 Recruiting Rabin Medical Center 2025-12-31
NCT04309786 Somatization, Anxiety, and Disordered Sleep in Pediatric Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT04309786 Recruiting University of California, San Diego 2021-04-11
NCT04248296 Evaluate the Intestinal Microbiome in Patients With Erosive Gastroesophageal Reflux Disease and in Asymptomatic Healthy Controls https://ClinicalTrials.gov/show/NCT04248296 Completed University of Sao Paulo General Hospital 2019-02-20
NCT03835663 The Bacterial Composition of the Stomach in Reflux Disease https://ClinicalTrials.gov/show/NCT03835663 Recruiting Imperial College London 2019-06-01
NCT03615950 Effects of Swallowed Steroids on Bone Density and Growth in Pediatric Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03615950 Recruiting Arkansas Children’s Hospital Research Institute 2020-08-01
NCT03581838 Eating With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT03581838 Completed Mayo Clinic 2019-07-23
NCT01194323 Biology in Patients With Reflux Esophagitis https://ClinicalTrials.gov/show/NCT01194323 Completed Vanderbilt University Medical Center 2012-12-31
NCT01170234 Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01170234 Completed Tufts Medical Center 2012-02-29
NCT00920400 Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract https://ClinicalTrials.gov/show/NCT00920400 Completed University Hospital, Basel, Switzerland 2009-09-30
NCT00901004 The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire https://ClinicalTrials.gov/show/NCT00901004 Completed AstraZeneca NA
NCT00859287 Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis https://ClinicalTrials.gov/show/NCT00859287 Completed AstraZeneca NA
NCT00842387 Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD) https://ClinicalTrials.gov/show/NCT00842387 Completed AstraZeneca NA
NCT03214081 Special Drug Use Surveillance of Vonoprazan for “Maintenance Therapy of Reflux Esophagitis: Long-term Use” https://ClinicalTrials.gov/show/NCT03214081 Completed Takeda 2018-08-31
NCT03290482 Natural History of Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03290482 Recruiting Mayo Clinic 2020-07-01
NCT03812575 The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03812575 Recruiting The University of Texas Health Science Center, Houston 2020-02-28
NCT02434705 Food Antigen in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02434705 Recruiting Mayo Clinic 2021-05-31
NCT01742377 Minimal Change Esophagitis by i-Scan Endoscopy in Dyspeptic Patients https://ClinicalTrials.gov/show/NCT01742377 Completed Prince of Songkla University 2014-07-31
NCT03980886 Characteristics and Inflammatory Markers in Children With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT03980886 Recruiting University of California, San Diego 2028-12-17
NCT00677378 Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain https://ClinicalTrials.gov/show/NCT00677378 Completed Medical College of Wisconsin 2014-12-31
NCT00667524 Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation https://ClinicalTrials.gov/show/NCT00667524 Completed University of Bern 2009-03-31
NCT00586963 Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis https://ClinicalTrials.gov/show/NCT00586963 Completed Mayo Clinic 2008-10-31
NCT00579410 Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule https://ClinicalTrials.gov/show/NCT00579410 Completed Kansas City Veteran Affairs Medical Center 2009-10-31
NCT00272818 Study to Identify Non-Invasive Markers of Gastrointestinal Allergy https://ClinicalTrials.gov/show/NCT00272818 Completed Boston Children’s Hospital 2008-06-30
NCT00267475 Data Bank for Eosinophilic Disorders https://ClinicalTrials.gov/show/NCT00267475 Completed Children’s Hospital Medical Center, Cincinnati 2012-12-31
NCT00256529 Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia https://ClinicalTrials.gov/show/NCT00256529 Completed University of Utah 2011-07-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03382678 CEGIR 7807: Validation of Online Cohort of EGID Patients Enrolled in RDCRN CEGIR Contact Registry https://ClinicalTrials.gov/show/NCT03382678 Enrolling by invitation Children’s Hospital Medical Center, Cincinnati 2019-08-01
NCT03824431 High Definition Endoscopy With NBI. Contribution in Patients With Non-erosive Esophagitis https://ClinicalTrials.gov/show/NCT03824431 Completed University of Sao Paulo General Hospital 2016-11-04
NCT03822325 Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03822325 Active, not recruiting Ann & Robert H Lurie Children’s Hospital of Chicago 2015-05-31
NCT04100005 A Pilot Study to Explore the Role of Gut Flora in Crohn’s Disease https://ClinicalTrials.gov/show/NCT04100005 Recruiting ProgenaBiome 2023-03-31
NCT03858426 Prospective Multicenter Nationwide Registry of Children With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03858426 Recruiting Sociedad Espanola de Gastroenterologia, Hepatologia y Nutricion Pediatrica 2020-11-01
NCT03853772 The Johns Hopkins Heartburn Center Registry https://ClinicalTrials.gov/show/NCT03853772 Enrolling by invitation Johns Hopkins University 2025-12-31